alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 31.2****CERTIFICATION PURSUANT TO****EXCHANGE ACT RULE 13a-14(a)**I, David Thompson, certify that:1. I have reviewed this Report on Form 10-Q of International Absorbents Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  (b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  (c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions): (a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and  (b) Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.        Date: June 13, 2007  /s/  David H. Thompson           David H. Thompson   *Secretary and Chief Financial Officer*
# m8809.docx

EUROPEAN COMMISSION Brussels, 27.03.2018 C(2018) 2024 final To the notifying parties: Subject : Case M. 8809 - Prime Credit 3 / Oxalis Holding / Lennon / Tavani / Lo Giudice / Phoenix Asset Management Commission decision pursuant to Article 6(1 )( b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 5 March 2018 , the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which Prime Credit 3 S.à r.l . ("PC3", Luxembourg), Oxalis Holding S.à r.l . ("Oxalis", Luxembourg), Mr Steve Lennon (Italy), Mr Paolo Lo Giudice (Italy) and Mr Roberto Tavani (Italy) acquire within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control of the whole of Phoenix Asset Management S.p.A ("PAM", the Target, Italy). The concentration is accomplished by way of purchase of shares . 3 2. The business activities of the undertakings concerned are: - PC3: a private equity firm focused on the European financial services sector which predominantly invests in non-performing assets comprising loans, leases, securities or other obligations; - Oxalis: a subsidiary and investment platform of funds managed by Pacific Investment Management company LLC (“PIMCO”, USA) . PIMCO is a global investment manager and provides fianancial services, among others, to governments, insurance companies, high-net-worth investors, financial institutions, retail investors and pooled investment vehicles; - Mr Steve Lennon, Paolo Lo Giudice and Mr Roberto Tavani : original shareholders of PAM, currently exercising joint control over PAM; - PAM: a company focused predominantly on the management of secured and unsecured non-performing loan (NPL) portfolios. 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 ( a ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1 )( b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission (Signed) Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 95 , 13.3.2018 , p. 23 .
(4)
OJ C 366, 14.12.2013, p. 5 .
#### Smith *v.*The State.

[No. 19,159.

Filed January 26, 1900.]

*Appeal.*— Failure *to Discuss Errors Assigned.*— Waiver.—Errors not discussed by appellant in bis brief are waived, *p. 107.*

*Same.*— Bill *of Exceptions.*— Instructions.—Instructions in a criminal case can only be brought into the record by bill of exceptions. *p. 107.*

Erom the Warren Circuit Gourt.

*Affirmed,*

*J. A. Lindley*and *O. P. Lewis,*for appellant.

*W. L. Taylor,*Attorney-General, *J. W. Brissey, A. T. Iñvengood*and *V. IS. IAvengood, for*State.

Hadley, C. J.

Appellant was convicted, under §2116 Burns 1894, §2029 R. S. 1881 an<l Horner 1897, of aiding a prisoner to escape.

The errors assigned challenge (1) the action of the court in overruling appellant’s motion to quash the affidavit and information, and (2) the overruling of his motion for a new trial. No infirmity in the affidavit and information is pointed out, and the first assignment is therefore waived under the often repeated rule of this court. *Dunn*v. *Dunn,*149 Ind. 424.

As a cause for a new trial it is urged that the court erred in giving, of its own motion, instruction number three. The instructions are not in the record. We find copied into the record, but not in a bill of exceptions, what purports to he a set of instructions; but there appears no prefatory recitals of the clerk, no exceptions, no signature of court or attorney, nor any other evidence that they were the instructions given to the jury; besides, it is firmly settled by a long line of decisions that instructions in a criminal case can only be brought into the record by a bill of exceptions. *Bealer*v. *State,*150 Ind. 390, and cases'cited.

The only other question argued is the sufficiency of the evidence to support the verdict. The evidence is in sharp conflict. We have no power to weigh it, and hence can not disturb the judgment. Judgment affirmed.
# Fourth Court of Appeals

**San Antonio, Texas**

January 25, 2023

No. 04

- 22

- 00814

- CV

IN THE INTEREST OF A.A.A. , a Child

From the 341st Judicial District Court

, Webb County, Texas

Trial Court No. 2020

- FLD

- 001240

- D3

Honorable Selina Nava Mireles , Judge Presiding

ORDER

In accordance with this court’s opinion of this date, this appeal is DISMISSED FOR LACK OF JURISDICTION. All pending motions, including notifications of late record, are DENIED AS MOOT. Because appellant is indigent, no costs of this a ppeal are assessed.

It is so ORDERED on January 25, 2023

.

_____________________ ________ Luz Elena D. Chapa , Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 25th day of January, 2023

.

_____________________________ Michael A. Cruz , Clerk of Court
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1370 Inositol. ( a ) Inositol, or myo-inositol (C6H12O6, CAS Reg. No. 87-89-8), is *cis*-1,2,3,5-*trans*-4,6-cyclohexanehexol. It occurs naturally and is prepared from an aqueous (0.2 percent sulfur dioxide) extract of corn kernels by precipitation and hydrolysis of crude phytate.
( b ) The ingredient meets the specifications of the Food Chemicals Codex, 3d Ed. (1981), p. 150, which is incorporated by reference. Copies are available from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( c ) In accordance with § 184.1(b)(1), the ingredient is used in food with no limitations other than current good manufacturing practice. The affirmation of this ingredient as generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used as a nutrient supplement as defined in § 170.3(o)(20) of this chapter.
( 2 ) The ingredient is used in special dietary foods as defined in part 105 of this chapter at levels not to exceed current good manufacturing practice. It may also be used in infant formula in accordance with section 412(g) of the Act, or with regulations promulgated under section 412(a)(2) of the Act.
( d ) Prior sanctions for this ingredient different from the uses established by this section do not exist or have been waived.
[47 FR 38278, Aug. 31, 1982]
Exhibit 00.2


                                  NEWS RELEASE

Media Contact:
Daryn Teague

Teague Communications
(661) 297-5292 or teaguecomm@aol.com


Legal Research Center Expands Relationship

With Integrity Interactive Corp.


Minneapolis - September 17, 2001 -Legal Research Center,  Inc. (OTC:  LRCI), the
nation's  leading  provider of outsourced  legal research and writing  services,
today  announced  that it has expanded its  strategic  alliance  with  Integrity
Interactive Corp. for producing and marketing industry-leading,  Web-based legal
compliance training.

     The LRC/Integrity  alliance was launched last summer and immediately thrust
LRC into the online legal  compliance  training  business.  The relationship has
been extremely successful for both companies, including a rapidly growing number
of e-training sales to Fortune 1000 United States corporations.

     "LRC and Integrity are generating  significant  business together,  so just
one year into our relationship we have mutually agreed to expand our contractual
agreement,"  said  Christopher  Ljungkull,  LRC's  CEO.  "It's  clear  that  our
collective  expertise  in the field of corporate  compliance  is creating a real
powerhouse   team   in   the   legal   services   marketplace   for   delivering
industry-leading Web-based compliance training."

     Leveraging the power of IIC's Internet learning technology,  LRC delivers a
fully-integrated  training  process to its corporate  customers - including risk
assessment,   individualized  story-based  training,  automated  administration,
integrated  testing,  and secure  reporting.  Current course  offerings  include
antitrust,  workplace  harassment,  insider trading,  export control,  gifts and
conflicts of interest,  intellectual property and electronic communications.  In
addition to developing  legal research  content for the Integrity  courses,  LRC
holds an equity stake in the company.

     Legal  Research  Center  (www.lrci.com)  offers legal  research and writing
services to attorneys in corporate and private  practice  throughout  the world.
Based in Minneapolis and founded in 1978, LRC's work products include


<PAGE>


compliance-related  multijurisdictional  surveys,  office memoranda,  and formal
court-ready  documents  such as trial  and  appellate  briefs.  LRC's  knowledge
management  services  include work  product  database  design and  facilitation,
Website content creation,  and compliance training.  LRC's nationally recognized
research  attorneys are honors graduates who have practiced law for at least two
years,  and many for over 25, in major law firms and corporate  law  departments
throughout the U.S.
[PORTIONS OF THIS EXHIBIT HAVE BEEN REDACTED PURSUANT TO A REQUEST FOR
CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
COMMISSION.]

                                  APPENDIX A-5

                                    PRODUCTS


Product Name:     HOT DOG EXPRESS, Part # RG-99

Product Description: Kitchen Appliance that mainly cooks Hot Dogs

Projected Units Sold next 24 months: XXXXXX

Manufacturer:     CirTran-Asia

Sub-Manufacturer: XXXXXX
                  XXXXXX
                  XXXXXX

Marketing Partner Contact Info:     EMSON PRODUCTS, INC.

Current Sale Price: $XXXXXX USD - CIRTRAN-ASIA

Current Cost to Manufacturer:       $XXXXXX USD

Total Tooling/Development Costs:    $100,000 USD

Gross Profit Margin Per Unit - $XXXXXX

                         CirTran-Asia $XXXXXX USD
                               XXXXXX $XXXXXX USD

Hot Dog Express Stock Option Schedule

Upon full execution of this Agreement, Cirtran's parent CirTran Corporation will
issue the following options to purchase restricted common stock:

                           Charles Ho                700,000 shares
                           Michael Casey             300,000 shares

These initial options will vest and be exercisable only after Cirtran has sold
300,000 HOT DOG EXPRESS units. The options will be exercisable at $.06 per share
after vesting. The options will expire and will no longer be exercisable on the
date one year after the date hereof.

In addition, for each whole multiple of 100,000 HOT DOG units sold by Cirtran
during the first 24 months of this Agreement in excess of the initial 300,000
units, CirTran Corporation will grant each Charles Ho and Michael Casey an
option to purchase 100,000 shares. Each such additional option will be
exercisable for a period of 12 months at an exercise price equal to the fair
market value of CirTran Corporation stock on the date of grant (i.e. the mean
between the high bid and low asked prices for the stock for the date of
determination).

As a condition to grant of the options, each option holder will be required to
make standard investment representations to CirTran Corporation.

[XXXXX - REDACTED PURSUANT TO REQUEST FOR CONFIDENTIAL TREATMENT FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION.]
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                           7,160
<SECURITIES>                                    39,321
<RECEIVABLES>                                    1,712
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                49,671
<PP&E>                                          14,155
<DEPRECIATION>                                   4,193
<TOTAL-ASSETS>                                  62,811
<CURRENT-LIABILITIES>                           16,182
<BONDS>                                         11,292
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            15
<OTHER-SE>                                      35,337
<TOTAL-LIABILITY-AND-EQUITY>                    62,811
<SALES>                                              0
<TOTAL-REVENUES>                                 3,134
<CGS>                                                0
<TOTAL-COSTS>                                   20,826
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 202
<INCOME-PRETAX>                               (17,386)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (17,386)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (17,386)
<EPS-PRIMARY>                                   (1.23)
<EPS-DILUTED>                                   (1.23)
        

</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary

          - [Docket ID: DOD-2010-HA-0177]

# AGENCY:

Office of the Assistant Secretary of Defense for Health Affairs, DoD.

# ACTION:

Notice; correction.

# SUMMARY:

                        On Tuesday, December 28, 2010 (75 FR 81242), the Department of Defense published a notice seeking comment on a new proposed public information collection: Traumatic Brain Injury, Post-Traumatic Stress Disorder, and Long-Term Quality of Life Outcomes in Injured Tri-Service U.S. Military Personnel; OMB Control Number 0720-TBD. The notice contained an incomplete phone number in the                         **FOR FURTHER INFORMATION CONTACT**                         section. The correct information follows.                    

# FOR FURTHER INFORMATION CONTACT:

                        To request more information on this proposed information collection or to obtain a copy of the proposal and associated collection instruments, please write to:                         *Commanding Officer, Naval Health Research Center, ATTN: Michael Galarneau, MS, NREMT, Code 161, 140 Sylvester Road, San Diego, CA 92106, or call at (619) 553-8411. (this is not a toll-free number).*

Dated: December 30, 2010.

Morgan F. Park,

Alternate OSD Federal Register Liaison Officer, Department of Defense.

[FR Doc. 2010-33263 Filed 1-4-11; 8:45 am]

BILLING CODE 5001-06-P
Electronically Filed

Intermediate Court of Appeals

CAAP-13-0001761

27-AUG-2014

07:56 AM
[No. 21530-6-II.

Division Two.

October 31, 1997.]

#### Kenneth W. Jackson, *Respondent,*v. The Boeing Company, *Appellant.*

Appeal from a judgment of the Superior Court for Pierce County, No. 95-2-00611-1, Thomas R. Sauriol, J., entered December 13, 1996. *Affirmed*by unpublished opinion per Bridgewater, A.C.J., concurred in by Morgan and Hunt, JJ.
<PAGE>   1

                                                                    EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the use in this Registration Statement on Form S-1 of our
report dated March 17, 1999, except as to the third through sixth paragraphs of
Note 12, which are as of May 11, 1999, and except as to the seventh paragraph of
Note 12 which is as of May 14, 1999, relating to the financial statements of
N2H2, Inc. which appears in such Registration Statement. We also consent to the
references to us under the headings "Experts" and "Selected Financial Data" in
such Prospectus. However, it should be noted that PricewaterhouseCoopers LLP has
not prepared or certified such "Selected Financial Data" in such Registration
Statement.

PricewaterhouseCoopers LLP
Seattle, Washington
July 20, 1999
# L_2019025EN.01002301.xml

| 29.1.2019 | EN | Official Journal of the European Union | L 25/23 |
| --- | --- | --- | --- |

29.1.2019

EN

Official Journal of the European Union

L 25/23

---

COUNCIL DECISION (CFSP) 2019/135

of 28 January 2019

amending Decision 2011/72/CFSP concerning restrictive measures directed against certain persons and entities in view of the situation in Tunisia

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Article 29 thereof,

Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,

Whereas:

| (1) | On 31 January 2011 the Council adopted Decision 2011/72/CFSP (1) concerning restrictive measures directed against certain persons and entities in view of the situation in Tunisia. |
| --- | --- |

(1)

On 31 January 2011 the Council adopted Decision 2011/72/CFSP (1) concerning restrictive measures directed against certain persons and entities in view of the situation in Tunisia.

| (2) | On the basis of a review of Decision 2011/72/CFSP, the restrictive measures should be extended until 31 January 2020 and the entry for one person should be removed. |
| --- | --- |

(2)

On the basis of a review of Decision 2011/72/CFSP, the restrictive measures should be extended until 31 January 2020 and the entry for one person should be removed.

| (3) | Decision 2011/72/CFSP should therefore be amended accordingly, |
| --- | --- |

(3)

Decision 2011/72/CFSP should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Decision 2011/72/CFSP is amended as follows:

| (1) | Article 5 is replaced by the following:

  ‘Article 5
  This Decision shall apply until 31 January 2020. It shall be kept under constant review. It may be renewed or amended, as appropriate, if the Council deems that its objectives have not been met.’ |
| --- | --- |

(1)

Article 5 is replaced by the following:

‘Article 5

This Decision shall apply until 31 January 2020. It shall be kept under constant review. It may be renewed or amended, as appropriate, if the Council deems that its objectives have not been met.’

| (2) | the Annex is amended in accordance with the Annex to this Decision. |
| --- | --- |

(2)

the Annex is amended in accordance with the Annex to this Decision.

Article 2

This Decision shall enter into force on the day following that of its publication in the Official Journal of the European Union.

Done at Brussels, 28 January 2019.

For the Council

The President

P. DAEA

---

(1)  Council Decision 2011/72/CFSP of 31 January 2011 concerning restrictive measures directed against certain persons and entities in view of the situation in Tunisia (OJ L 28, 2.2.2011, p. 62).

1

---

ANNEX

In the Annex to Decision 2011/72/CFSP, entry 28 (Mohamed Marwan Ben Ali Ben Mohamed MABROUK) is deleted.

---